| http://www.w3.org/ns/prov#value | - The invention further relates to the use of a dsRNA or a pharmaceutical composition containing a dsRNA for treatment of a metabolic disorder, such as diabetes, in combination with other pharmaceuticals and/or other therapeutic methods, e.g., with known pharmaceuticals and/or known therapeutic methods, such as, for example, those which are currently employed for treating metabolic disorders (e.g.,
|
